First Report of New Delhi Metallo-β-Lactamase Carbapenemase–Producing Acinetobacter baumannii in Peru

Authors

• Claudio Rocha, U.S. Naval Medical Research Unit No. 6Follow
• Manuela Bernal, U.S. Naval Medical Research Unit No. 6
• Enrique Canal, U.S. Naval Medical Research Unit No. 6
• Paul Rios, U.S. Naval Medical Research Unit No. 6
• Rina Meza, U.S. Naval Medical Research Unit No. 6
• Miguel Lopez, U.S. Naval Medical Research Unit No. 6
• Rosa Burga, U.S. Naval Medical Research Unit No. 6
• Ricardo Abadie, U.S. Naval Medical Research Unit No. 6
• Melita Pizango, U.S. Naval Medical Research Unit No. 6
• Elia Diaz, Hospital Regional de Loreto
• Alexander Briones, Hospital Regional de Loreto
• Cesar Ramal-Asayag, Hospital Regional de Loreto
• William Vicente, Instituto Nacional de Enfermedades Neoplasicas
• James Regeimbal, U.S. Naval Medical Research Unit No. 6Follow
• Andrea McCoy, U.S. Naval Medical Research Unit No. 6

Date of this Version

2019

Citation

Am. J. Trop. Med. Hyg., 100(3), 2019, pp. 529–531

Comments

Copyright © 2019 by The American Society of Tropical Medicine and Hygiene

This document is a U.S. government work and is not subject to copyright in the United States.

doi:10.4269/ajtmh.18-0802

Abstract

Here we report the first incidence of New Delhi metallo-β-lactamase (NDM-1)–producing Acinetobacter baumannii in Peru, identified via a strain-based nosocomial surveillance project carried out in Lima and Iquitos. The bla_NDM-1 gene was detected by multiplex polymerase chain reaction (PCR) and confirmed by loci sequencing. Acinetobacter baumannii is a nearly ubiquitous and promiscuous nosocomial pathogen, and the acquisition of bla_NDM-1 by A. baumannii may facilitate an increase in the prevalence of this important resistance marker in other nosocomial pathogens.